vs

Side-by-side financial comparison of PagerDuty, Inc. (PD) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $124.5M, roughly 1.6× PagerDuty, Inc.). PagerDuty, Inc. runs the higher net margin — 129.7% vs 6.7%, a 123.0% gap on every dollar of revenue. On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs 4.7%). PagerDuty, Inc. produced more free cash flow last quarter ($24.1M vs $17.6M). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs 5.9%).

PagerDuty, Inc. is an American cloud computing company specializing in a SaaS incident management platform for IT operations departments.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

PD vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.6× larger
RGEN
$197.9M
$124.5M
PD
Growing faster (revenue YoY)
RGEN
RGEN
+8.9% gap
RGEN
13.6%
4.7%
PD
Higher net margin
PD
PD
123.0% more per $
PD
129.7%
6.7%
RGEN
More free cash flow
PD
PD
$6.5M more FCF
PD
$24.1M
$17.6M
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
5.9%
PD

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PD
PD
RGEN
RGEN
Revenue
$124.5M
$197.9M
Net Profit
$161.6M
$13.3M
Gross Margin
85.3%
52.5%
Operating Margin
6.5%
9.0%
Net Margin
129.7%
6.7%
Revenue YoY
4.7%
13.6%
Net Profit YoY
2827.7%
143.9%
EPS (diluted)
$1.69
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PD
PD
RGEN
RGEN
Q4 25
$124.5M
$197.9M
Q3 25
$123.4M
$188.8M
Q2 25
$119.8M
$182.4M
Q1 25
$121.4M
$169.2M
Q4 24
$118.9M
$174.1M
Q3 24
$115.9M
$154.9M
Q2 24
$111.2M
$154.1M
Q1 24
$111.1M
$151.3M
Net Profit
PD
PD
RGEN
RGEN
Q4 25
$161.6M
$13.3M
Q3 25
$9.6M
$14.9M
Q2 25
$-7.2M
$14.9M
Q1 25
$-8.8M
$5.8M
Q4 24
$-5.9M
$-30.3M
Q3 24
$-10.9M
$-654.0K
Q2 24
$-17.1M
$3.3M
Q1 24
$-28.2M
$2.1M
Gross Margin
PD
PD
RGEN
RGEN
Q4 25
85.3%
52.5%
Q3 25
84.6%
53.2%
Q2 25
84.0%
50.0%
Q1 25
83.6%
53.6%
Q4 24
83.0%
26.1%
Q3 24
82.7%
50.0%
Q2 24
82.6%
49.8%
Q1 24
81.7%
49.5%
Operating Margin
PD
PD
RGEN
RGEN
Q4 25
6.5%
9.0%
Q3 25
2.9%
8.9%
Q2 25
-8.6%
7.6%
Q1 25
-9.6%
3.9%
Q4 24
-8.7%
-17.7%
Q3 24
-13.8%
-5.1%
Q2 24
-19.5%
1.0%
Q1 24
-30.1%
1.3%
Net Margin
PD
PD
RGEN
RGEN
Q4 25
129.7%
6.7%
Q3 25
7.8%
7.9%
Q2 25
-6.0%
8.2%
Q1 25
-7.2%
3.4%
Q4 24
-5.0%
-17.4%
Q3 24
-9.4%
-0.4%
Q2 24
-15.4%
2.2%
Q1 24
-25.3%
1.4%
EPS (diluted)
PD
PD
RGEN
RGEN
Q4 25
$1.69
$0.24
Q3 25
$0.10
$0.26
Q2 25
$-0.07
$0.26
Q1 25
$-0.12
$0.10
Q4 24
$-0.07
$-0.55
Q3 24
$-0.14
$-0.01
Q2 24
$-0.26
$0.06
Q1 24
$-0.34
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PD
PD
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$547.8M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$320.5M
$2.1B
Total Assets
$1.0B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PD
PD
RGEN
RGEN
Q4 25
$547.8M
$767.6M
Q3 25
$567.9M
$748.7M
Q2 25
$597.1M
$708.9M
Q1 25
$570.8M
$697.2M
Q4 24
$542.2M
$757.4M
Q3 24
$599.3M
$784.0M
Q2 24
$592.8M
$809.1M
Q1 24
$571.2M
$780.6M
Total Debt
PD
PD
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
$484.5M
Q4 24
$525.6M
Q3 24
Q2 24
Q1 24
$489.5M
Stockholders' Equity
PD
PD
RGEN
RGEN
Q4 25
$320.5M
$2.1B
Q3 25
$180.7M
$2.1B
Q2 25
$145.7M
$2.1B
Q1 25
$129.8M
$2.0B
Q4 24
$111.6M
$2.0B
Q3 24
$164.7M
$2.0B
Q2 24
$174.0M
$2.0B
Q1 24
$171.6M
$2.0B
Total Assets
PD
PD
RGEN
RGEN
Q4 25
$1.0B
$2.9B
Q3 25
$891.5M
$2.9B
Q2 25
$926.8M
$2.9B
Q1 25
$927.3M
$2.9B
Q4 24
$866.8M
$2.8B
Q3 24
$916.0M
$2.8B
Q2 24
$924.0M
$2.9B
Q1 24
$925.3M
$2.8B
Debt / Equity
PD
PD
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
3.73×
Q4 24
0.27×
Q3 24
Q2 24
Q1 24
2.85×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PD
PD
RGEN
RGEN
Operating Cash FlowLast quarter
$24.8M
$25.7M
Free Cash FlowOCF − Capex
$24.1M
$17.6M
FCF MarginFCF / Revenue
19.3%
8.9%
Capex IntensityCapex / Revenue
0.6%
4.1%
Cash ConversionOCF / Net Profit
0.15×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$117.6M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PD
PD
RGEN
RGEN
Q4 25
$24.8M
$25.7M
Q3 25
$34.0M
$48.1M
Q2 25
$30.7M
$28.6M
Q1 25
$31.4M
$15.0M
Q4 24
$22.1M
$39.2M
Q3 24
$35.8M
$49.3M
Q2 24
$28.6M
$42.2M
Q1 24
$22.2M
$44.7M
Free Cash Flow
PD
PD
RGEN
RGEN
Q4 25
$24.1M
$17.6M
Q3 25
$33.1M
$43.4M
Q2 25
$30.2M
$21.5M
Q1 25
$30.3M
$11.4M
Q4 24
$21.5M
$33.6M
Q3 24
$35.1M
$42.3M
Q2 24
$28.2M
$37.4M
Q1 24
$21.2M
$36.4M
FCF Margin
PD
PD
RGEN
RGEN
Q4 25
19.3%
8.9%
Q3 25
26.8%
23.0%
Q2 25
25.2%
11.8%
Q1 25
24.9%
6.8%
Q4 24
18.1%
19.3%
Q3 24
30.3%
27.3%
Q2 24
25.4%
24.3%
Q1 24
19.1%
24.0%
Capex Intensity
PD
PD
RGEN
RGEN
Q4 25
0.6%
4.1%
Q3 25
0.7%
2.5%
Q2 25
0.4%
3.9%
Q1 25
0.9%
2.1%
Q4 24
0.5%
3.2%
Q3 24
0.5%
4.5%
Q2 24
0.4%
3.1%
Q1 24
0.9%
5.5%
Cash Conversion
PD
PD
RGEN
RGEN
Q4 25
0.15×
1.93×
Q3 25
3.55×
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PD
PD

US$88.8M71%
Non Us$35.7M29%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons